Searchable abstracts of presentations at key conferences in endocrinology

ea0095oc10.6 | Oral Communications 10 | BSPED2023

An appraisal on the quality and readability of growth hormone therapy patient information developed by paediatric endocrine societies

McKechnie Jennifer , Qian Ho Zhe , Mason Avril , Wong Sze Choon

Background: In the UK, recombinant human growth hormone(rhGH) is approved for children with growth failure associated with six different conditions. According to NICE guidelines, clinicians should have a comprehensive discussion with patients and/or caregivers about treatment options. Research shows that patients retain only about 20% of the information provided during a consultation. This can be improved to around 50% when written information is also provided...